Skip to main content

Search This Blog

Pulmonary Hypertension

Posts

Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association | Circulation

Get link
Facebook
X
Pinterest
Email
Other Apps

January 04, 2026

Invalid Access Key! Invalid Access Key!

AFib and Heart Failure: Does One Lead to the Other?

Get link
Facebook
X
Pinterest
Email
Other Apps

January 04, 2026

Invalid Access Key! Invalid Access Key!

Diastolic Heart Failure: What Is It?

Get link
Facebook
X
Pinterest
Email
Other Apps

January 04, 2026

Invalid Access Key! Invalid Access Key!

Congestive Heart Failure: What Does It Mean?

Get link
Facebook
X
Pinterest
Email
Other Apps

January 04, 2026

Invalid Access Key! Invalid Access Key!

Chronic Thromboembolic Pulmonary Hypertension

Get link
Facebook
X
Pinterest
Email
Other Apps

January 04, 2026

Invalid Access Key! Invalid Access Key!

Congestive Heart Failure: What Does It Mean?

Get link
Facebook
X
Pinterest
Email
Other Apps

January 03, 2026

Invalid Access Key! Invalid Access Key!

Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association | Circulation

Get link
Facebook
X
Pinterest
Email
Other Apps

January 03, 2026

Invalid Access Key! Invalid Access Key!

Powered by Blogger

Theme images by 4x6

Archive

January18
December24
November48
October76
September59
August77
July70
June61
May79
April89

Show more Show less

Popular posts from this blog

Tyvaso (treprostinil) Drug Overview & Product Profile 2019 - ResearchAndMarkets.com - Yahoo Finance

Tyvaso (treprostinil) Drug Overview & Product Profile 2019 - ResearchAndMarkets.com - Yahoo Finance Tyvaso (treprostinil) Drug Overview & Product Profile 2019 - ResearchAndMarkets.com - Yahoo Finance Posted: 16 Jul 2019 07:58 AM PDT DUBLIN--(BUSINESS WIRE)-- The "Tyvaso" report has been added to ResearchAndMarkets.com's offering. United Therapeutics developed Tyvaso (treprostinil) as a follow-on product to Remodulin. As an inhaled formulation of treprostinil, Tyvaso is better tolerated than continuously and subcutaneously administered Remodulin. Analyst Outlook United Therapeutics has created a large market niche for its inhaled treprostinil formulation, Tyvaso, despite the drug being relegated to later lines of therapy and being unavailable outside the US. However, this niche is now under threat from newer, more convenient oral prostacyclins such as Uptravi (selexipag; Johnson & Johnson/Nippon Shinyaku), wh...

Effect of perioperative sigh ventilation on postoperative hypoxemia and pulmonary complications after on-pump cardiac surgery (E-SIGHT): study protocol for a randomized controlled trial

lung infection pain :: Article Creator Medical Minute: Pleurisy Linked To Common Viral Infections Often Goes Undiagnosed In Children The winter season is notorious for a surge in illnesses like the flu, COVID-19, and RSV, which can trigger serious complications such as pleurisy, an inflammatory lung condition causing sharp chest pain. Sunday, February 23rd 2025, 11:33 am By: LeAnne Taylor TULSA, Okla. - The winter season is infamous for its rise in illnesses such as the flu, COVID-19, and RSV. These viral infections can lead to other medical conditions such as Pleurisy. Pleurisy is an inflammation of the lung lining, which causes sharp pain particularly during large breaths, coughing, or resting in certain positions. Additional symptoms of pleurisy include coughing, shortness of breath, fever, and difficulty swallowing. Pleurisy often goes unidentified in children due to a common struggle to explain their pain accurately for diagnosis....

Increased Risk for Adverse Outcomes With Mild Pulmonary Hypertension in HFpEF - The Cardiology Advisor

Increased Risk for Adverse Outcomes With Mild Pulmonary Hypertension in HFpEF - The Cardiology Advisor Increased Risk for Adverse Outcomes With Mild Pulmonary Hypertension in HFpEF - The Cardiology Advisor Posted: 20 May 2019 01:00 AM PDT Patients with heart failure with preserved ejection fraction (HFpEF) who have mild pulmonary hypertension (PH) are at increased risk for adverse clinical outcomes, according to a review published in the American Journal of Respiratory and Critical Care Medicine . 1 PH is a prevalent HFpEF subphenotype that is due to pulmonary venous and pre-capillary remodeling from left atrial hypertension. 3-5 Previous studies conducted in the United States have demonstrated a wide continuum of clinical risk relative to mean pulmonary artery pressure (mPAP), including hospitalization and mortality, which changed the mPAP threshold for defining PH in the setting of left heart disease from >25 mmHg to >20 mmHg. 2,6...

Labels

"pulmonary hypertension prognosis" - Google News
idiopathic pulmonary hypertension
IFTTT
mild pulmonary hypertension
pulmonary artery hypertension
Pulmonary Hypertension
pulmonary hypertension causes
pulmonary hypertension diagnosis
pulmonary hypertension medications
pulmonary hypertension prognosis

pulmonary hypertension symptoms
pulmonary hypertension treatment
severe pulmonary hypertension
what is pulmonary hypertension

Show more Show less

yand